Recent Updates
Recently added Catalysts
PRAX Positive Sentiment

Praxis Precision Medicines to Participate in TD Cowen’s 44th Annual Health Care Conference

Friday, March 1, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Praxis Precision Medicines, Inc. will participate in the TD Cowen 44th Annual Health Care Conference located in Boston from March 4 to 6, 2024. The company's management will engage in investor meetings and take part in a corporate panel discussion titled 'Orphan Epilepsies Corporate Panel Discussion' on March 6 at 10:30 a.m. EST. This event aims to highlight their developments related to CNS disorders. A replay of the webcast will be accessible on the company's website for 90 days afterwards.
Price reaction · baseline $46.78 (2024-02-29 close) · hit after-hours · 1 other PRAX headline(s) in the window, move may be shared
day 0 close
+5.9%
day 1
+17%
day 3 · peak
+24.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a significant healthcare conference, enhancing visibility.
  • Opportunity for one-on-one investor meetings, indicating investor interest.
  • Panel discussion focused on orphan epilepsies may attract specialized attention.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+61%
120-day peak, hindsight
Typical move
23.7%
average across 12 past catalysts
Cash runway
~53 mo
Minimal dilution risk
Lead asset
vormatrogine
Phase 3 · Epilepsy, Tonic-Clonic

Full Press Release Details

BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in the TD Cowen 44th Annual Health Care Conference, taking place in Boston from March 4 – 6, 2024. In addition to conducting one-on-one investor meetings, management will participate in a corporate panel discussion.
Panel Discussion Details
Title: Orphan Epilepsies Corporate Panel Discussion
Date: Wednesday, March 6, 2024
Time: 10:30 a.m. EST
Webcast Link: Link
This live webcast will also be available through the Events & Presentations page of the Investors + Media section of the company’s website www.praxismedicines.com. A replay of the webcast will be available on Praxis’ website for 90 days following the event.

Frequently Asked Questions

What is the TD Cowen 44th Annual Health Care Conference?

It is a conference in Boston where Praxis Precision Medicines will participate.

When will Praxis's panel discussion occur?

The panel discussion is scheduled for March 6, 2024, at 10:30 a.m. EST.

How can I access the live webcast of the panel?

The live webcast can be accessed through Praxis's Events & Presentations page.

Will the webcast be available after the event?

Yes, a replay of the webcast will be available for 90 days post-event.

What is the topic of the corporate panel discussion?

The topic is the Orphan Epilepsies, focusing on related therapies.

ShareAdd on Google
Tags: PRAX Viatris Investor Conferences Healthcare Praxis Precision Medicines CNS disorders orphan epilepsies investor meetings health care conference
Last updated: Mar 1, 2024

Biotech snapshot

Cash runway
$1374M liquidity · $26M/mo burn
~53 mo
Minimal dilution risk
Lead asset
vormatroginePhase 3
Epilepsy, Tonic-Clonic →

Catalyst track record

+61%
best trade around PRAX's most recent catalyst

Peak hindsight return over a 120-day window, across 12 tracked FDA/PDUFA catalysts for PRAX.

See every catalyst's timing & PoA →